Based on the GSEA analysis, tumor-related signal pathways such as JAK-STAT, MAPK, p53 and NOTCH were significantly enriched, and continuous activation of these pathways has been confirmed to be linked with HCC, which would be new therapeutic targets (35–38). Here, TP53 is linked to hepatocellular carcinoma.